ASHLEY GRUBER: Open Payments
NPI 1972159697 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,941 in 134 payments from 17 companies in 2025. Trend: 2023 $2,714 · 2024 $2,200 · 2025 $2,941
Food & beverage: $2,718Education: $223
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 23 | $685 |
| GlaxoSmithKline, LLC. | 37 | $557 |
| AstraZeneca Pharmaceuticals LP | 17 | $497 |
| Novartis Pharmaceuticals Corporation | 15 | $341 |
| GENZYME CORPORATION | 11 | $242 |
| Amgen Inc. | 9 | $158 |
| CSL Behring | 3 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| Grifols USA, LLC | 3 | $59 |
| Optinose US, Inc. | 3 | $59 |
Products named: DUPIXENT, TRELEGY ELLIPTA, FASENRA, NUCALA, AIRSUPRA, TEZSPIRE, XOLAIR, Rhapsido.
Industry payments across FL — which companies pay providers there.
